Hostname: page-component-78c5997874-94fs2 Total loading time: 0 Render date: 2024-11-14T06:52:46.619Z Has data issue: false hasContentIssue false

Prevalent emm types and superantigen gene patterns of group A Streptococcus in Thailand

Published online by Cambridge University Press:  12 August 2015

W. PAVEENKITTIPORN
Affiliation:
National Institute of Health, Muang, Nonthaburi, Thailand
T. NOZAWA*
Affiliation:
Thailand-Japan Research Collaboration Center on Emerging and Reemerging Infections, Muang, Nonthaburi, Thailand Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan Department of Microbiology, Kyoto University, Kyoto, Japan
S. DEJSIRILERT
Affiliation:
National Institute of Health, Muang, Nonthaburi, Thailand
I. NAKAGAWA
Affiliation:
Department of Microbiology, Kyoto University, Kyoto, Japan
S. HAMADA
Affiliation:
Thailand-Japan Research Collaboration Center on Emerging and Reemerging Infections, Muang, Nonthaburi, Thailand Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan
*
*Author for correspondence: Dr T. Nozawa, Department of Microbiology, Kyoto University, Kyoto 606-8501, Japan. (Email: nozawa.takashi.4r@kyoto-u.ac.jp)
Rights & Permissions [Opens in a new window]

Summary

Group A Streptococcus (GAS) are globally distributed bacterial pathogens. We examined the emm genotypes, which are important indicators of virulence, of 349 clinical GAS isolates collected using two surveillance systems, i.e. Invasive Bacterial Infection Surveillance (IBIS) from 2010 to 2011 (234 isolates) and routine surveillance of clinically isolated bacteria from various hospitals during 1996–2011 (115 isolates) in Thailand. The major emm genotypes in IBIS samples were emm44 (12·0%), emm104 (6·8%), emm22 (5·6%), and emm81 (5·6%), whereas only one isolate (0·4%) had the emm1 genotype, which is significantly more common in invasive cases in the Western world. In samples collected during routine surveillance, emm238 (10·4%), emm44 (8·7%), and emm165 (7·0%) were dominant. The major superantigen gene profiles were similar between the groups, and 30·1% of isolates did not possess the phage-encoded superantigens (speA, speC, speH, speI, speK, speL, speM, ssa). Although most isolates exhibited limited gene profiles, emm44 isolates had highly variable gene profiles (15 patterns). We conclude that emm44 is the predominant GAS genotype in Thailand, and isolates varied in superantigen gene profiles.

Type
Short Report
Copyright
Copyright © Cambridge University Press 2015 

Group A Streptococcus (GAS), Streptococcus pyogenes, are among the most prevalent bacterial pathogens globally, causing a variety of acute infections (e.g. pharyngitis, skin infections, toxic shock syndrome, severe necrotizing fasciitis) and post-infectious sequelae (e.g. glomerulonephritis, rheumatic fever). The relative incidence of GAS diseases varies depending on both location and season [Reference Carapetis1].

GAS produces a range of virulence factors that contribute to the infectious process. The M protein, encoded by the emm gene, is one of the major virulence factors and promotes evasion of phagocytic killing. The M protein has traditionally been used for serological typing of GAS strains but this has recently been replaced by DNA sequencing of the 5′-end of the emm gene encoding the distal tip of the fibrillar M protein. To date, sequence typing has identified over 250 emm genotypes [Reference Facklam2].

The distribution of emm genotypes is important for informing local and global epidemiological trends of GAS infections. A meta-analysis by Steer et al. [Reference Steer3] showed that 25 emm types account for 90% of GAS in industrialized countries with the most prevalent type being emm1 (18·3%), followed by emm12 (11·1%), emm28 (8·5%), emm3 (6·9%), and emm4 (6·9%). However, in Africa and the Pacific regions, 26 emm types account for about 62% of isolates, which indicates a higher diversity of emm types in these regions, with a correspondingly lower prevalence of those types that are commonly found in industrial countries (e.g. emm1, emm4, emm6, emm12).

The distribution of emm types has been reported for some Asian countries, such as Japan, India, and China [Reference Steer3], but few reports are available on emm-type distribution in Southeast Asian countries, including Thailand. The aim of this study was to characterize the prevalence and distribution of emm genotypes in Thailand using sequence typing and superantigen gene analysis.

The Invasive Bacterial Infection Surveillance (IBIS) programme was initiated in 2010 to detect various bacterial pathogens – including S. pyogenes – from normally sterile body sites during routine diagnosis in the Thailand hospital network. This comprised 57 provincial hospitals located in the central, eastern, northern, northeastern, and southern regions of the country. In this project, 234 GAS isolates were obtained in 2010–2011 from blood (230), synovial fluid (2), joint fluid (1), and cerebrospinal fluid (1). An additional 115 GAS isolates were collected in 1996–2011 from pus (51), blood (40), throat (14), urine (3), sputum (2), joint fluid (1), endotrachea (1), ear (1), wound (1), and an unknown source (1) using routine surveillance of pathogenic bacteria from patients collected from various hospitals in Thailand by the Department of Medical Sciences, Ministry of Public Health, Thailand. IBIS is an active surveillance programme for invasive bacterial infections while routine surveillance is a passive system based on requests from various bacterial infections.

GAS isolates were identified by colony morphology, β-haemolysis on sheep blood agar, and bacitracin sensitivity. The emm gene was amplified by polymerase chain reaction using purified chromosomal DNA at a tenfold dilution followed by sequencing according to the protocol from the Centers for Disease Control and Prevention (CDC) Atlanta, GA, USA (http://www.cdc.gov/streplab/protocol-emm-type.html). A specific emm type of each isolate was determined if the first 180 bp of the test and reference emm sequences in the CDC database were identical (http://www.cdc.gov/ncidod/biotech/Strep/Strepblast.htm). Novel emm types or subtypes were determined by the curator of the emm sequence database.

Eight phage-encoded superantigen genes (speA, speC, speH, speI, speK, speL, speM, ssa) and three chromosomally encoded superantigen genes (speG, speJ, smeZ) were amplified separately using 11 previously described primer pairs [Reference Meisal4]. The superantigen gene distribution patterns were determined by the presence or absence of GAS superantigen genes. S. pyogenes SSI-1 (NCBI GenBank accession no: NC_004606), MGAS9429 (NC_008021), MGAS5005 (NC_007297), MGAS10270 (NC_008022), MGAS315 (NC_004070), and MGAS8232 (NC_003485) were used to validate the detection accuracy, and the precise identification of all superantigen genes tested was confirmed.

A total of 67 emm types was identified in 349 GAS isolates (Fig. 1). Within the isolates collected by IBIS, 58 emm types were identified and the prevalence rates were as follows: emm44 (12·0%), emm104 (6·8%), emm22 (5·6%), emm81 (5·6%), and emm75 (5·1%). The emm1 and emm12 genotypes, which are common in Western countries [Reference Steer3], represented only 0·4% and 2·6% of the total isolates, respectively. Of the isolates collected during routine surveillance, 42 emm types were found with prevalence rates as follows: emm238 (10·4%), emm44 (8·7%), emm165 (7·0%), emm88 (6·1%), and emm25 (5·2%).

Fig. 1. Distribution of emm types in group A Streptococcus isolates in Thailand. Bars represent the number of isolates from (a) the Invasive Bacterial Infection Surveillance (IBIS) programme and (b) routine surveillance.

The chromosomally encoded superantigen genes speG, speJ, and smeZ were found in 83·8%, 26·9% and 94·0% of the IBIS isolates, respectively, while the prophage-encoded superantigen genes speA, speC, speH, speI, speK, speL, speM, and ssa occurred in 9·0%, 30·3%, 35·0%, 26·1%, 15·4%, 19·2%, 30·8%, and 7·7%, of the isolates, respectively. Seventy superantigen patterns were identified and 14 widely distributed profiles of superantigen genes accounted for 61·1% of the total isolates (Table 1). Superantigen gene profiles A, B, and D, which were devoid of phage-encoded superantigen genes, accounted for 26·5% of the isolates. Most emm types exhibited limited gene profiles, e.g. 13/16 emm104 isolates were classified as profile C, and all 13 emm22 isolates belonged to profile A. The prevalent profiles in emm44 isolates were profiles I (six isolates), K (four isolates), and M (four isolates), and emm44 isolates were characterized by 15 profiles in total.

Table 1. Characterization of superantigen gene patterns and emm types of group A Streptococcus isolates in Thailand

IBIS, Invasive Bacterial Infection Surveillance.

In the routine surveillance isolates, speG, speJ, and smeZ were identified in 83·5%, 32·2%, and 83·5%, respectively, and speA, speC, speH, speI, speK, speL, speM, and ssa in 11·3%, 20·0%, 27·8%, 9·6%, 9·6%, 8·7%, 17·4%, and 5·4%, respectively. Thirty-seven superantigen patterns were identified and the top seven profiles accounted for 74·8% of the total isolates and contained the major superantigen gene profiles found in the IBIS isolates. Isolates of emm238 and emm165 exhibited emm-specific profiles, whereas emm44 isolates were variable in superantigen gene profiles (Table 1).

To our knowledge, this is the first nationwide survey to assess the distribution of emm genotypes and superantigen genes of clinical GAS isolates in Thailand. In total, 67 emm types were identified, the most prevalent type being emm44, which is rare in industrialized countries. Interestingly, emm1 and emm12 isolates, which are the most common in Western countries, are rare in Thailand. These findings suggest that GAS infections in Thailand are caused by diverse types of S. pyogenes and that the emm genotype distribution is distinctly different from those found in North America, Europe, North Africa, and East Asia [Reference Steer3].

In both surveillance systems the percentage of GAS isolates over all the bacterial isolates was 1·1% (115/10 896) in routine surveillance, and 8·3% (234/2826) in IBIS. GAS were isolated from various body sites (invasive and non-invasive) and over different time periods (IBIS 2010–2011; routine 1996–2011) and therefore, direct comparisons of type distributions between isolates from the two surveillance systems were not possible. However, emm44-type GAS were preferentially isolated in both systems, indicating that this type has been dominant in Thailand for decades. Interestingly, in the routine surveillance isolates, only a single representative from blood of 40 isolates (2·4%) was emm44. On the other hand, 7/50 non-sterile pus isolates (14·0%) and 2/14 throat swab isolates (14·3%) were emm44, respectively. Thus, emm44 GAS might not have been rare in non-invasive GAS in Thailand and corroborates its relative high frequency reported from non-invasive skin infections in Asia [Reference Steer3]. Consequently, our finding that 12% of IBIS isolates in 2010–2011 were of emm44 GAS is noteworthy.

As noted above the isolation of emm44 GAS has been documented in Asia [Reference Steer3, Reference Sakota5], and spread of an emm44 tetracycline-resistant GAS clone has been reported in France [Reference Cady6]. However, these have rarely been associated with invasive infections [Reference Steer3, Reference Luca-Harari7]. It is widely held that invasive infection is mostly associated with epidemic M1T1 clones that have acquired novel virulence genes coded by prophages or other mobile genetic elements in industrialized countries [Reference Nasser8]. By contrast, in Thailand the M1T1 clone is rare, irrespective of surveillance method, and emm44 GAS is the type most associated with invasive GAS infection. Since the distribution of epidemic pathogens often show a particular geographical pattern, we examined the relationship between specific emm type and the region from which they were obtained by IBIS. The geographical distribution of emm44 GAS isolates was: central (7·7%); east (6·5%); north (12·9%); northeast, (18·3%); and south (8·0%). This suggests a higher prevalence of this genotype in the north/northeast regions of Thailand.

We also identified a number (10·4%) of GAS of emm238 (previously termed ST11014) in routine surveillance isolates; this type is noted to be rare in several countries [Reference Rogers9, Reference Chen10]. By contrast, emm1 and emm12, which are associated with invasive infection in Western countries [Reference Steer3], were observed far less frequently (0·4% and 2·6%, respectively) in this study. These findings indicate that the emm types of GAS cause widespread infections in a population-specific manner, as previously suggested [Reference Rogers11].

Superantigens are associated with disease conditions such as scarlet fever and streptococcal toxic shock syndrome [Reference Commons12]. Of 11 superantigen genes known in GAS, speA, speC, speH, speI, speK, speL, speM, and ssa are located in the prophage region of the genome [Reference Commons12], while the rest are confined to chromosomal regions. This indicates that these genes are mainly acquired via horizontal gene transfer and their variation results from the acquisition or loss of prophages. In this study, we identified 75 unique superantigen gene profiles, suggesting the presence of diverse subclones of the GAS isolates in addition to the observed variation in emm type. All isolates possessed at least one of the three chromosomally encoded superantigen genes, speG (83·2%), speJ (28·6%), and smeZ (91·2%). Although these frequencies are in agreement with those reported for GAS isolates in other countries [Reference Commons12], the detection rates of the phage-encoded genes differed substantially from other studies; these genes were identified in <4% of isolates in Norway and Australia [Reference Meisal4, Reference Commons12], whereas about 30% of the isolates from Thailand possessed them.

Most of the isolates of a given emm type were associated with a single gene profile, with some variation that was likely due to the loss or acquisition of superantigen genes [Reference Meisal4, Reference Commons13]. Most isolates in this study showed emm-specific gene profiles, with a few exceptions. However, the emm44 GAS were not characterized by dominant emm profiles using either isolation method, and included 15 gene patterns. This suggests that emm44 GAS in Thailand might be able to acquire various phages, including the virulent phage related to invasive infection and their sensitivity to phage infection might differ from other emm-type GAS isolates. Clustered Regularly Interspaced Palindromic Repeat (CRIPR)/Cas system is known to be an anti-phage system in bacteria, which functions as adaptive immunity against foreign genetic elements including bacteriophages. We have previously reported that the CRIPR/Cas locus in S. pyogenes regulates prophage inhibition [Reference Nozawa14], and so it is therefore possible that these loci in emm44 GAS are attenuated or diminished, resulting in a variety of prophage integrations.

In conclusion, GAS emm types in Thailand exhibited a distribution pattern that differs from the patterns observed in other countries, and emm44 was prevalent. Although emm44 tended to be isolated from non-sterile specimens in routine surveillance and is known to be a non-invasive type in other Asian regions, a number of invasive emm44 GAS were identified in 2010–2011 IBIS isolates in Thailand. Furthermore, this genotype exhibited highly variable superantigen gene profiles. These findings not only add value to diagnosis and treatment for GAS infection in Thailand but also reveal the benefit and importance of an active surveillance system for this pathogen.

ACKNOWLEDGEMENTS

We are grateful to Wannaporn Jaroonlakana and other staff members at the Department of Medical Sciences, Thailand Culture Collection. We are also grateful to the research team of the Thai Invasive Bacterial Surveillance Programme, especially Professor Dr Sayomporn Sirinawin and Dr Henry Baggett, for providing the bacterial strains.

This work was supported by the Programme of Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) sponsored by the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a research grant from the Department of Medical Sciences, Ministry of Public Health of Thailand.

DECLARATION OF INTEREST

None.

References

REFERENCES

1. Carapetis, JR, et al. The global burden of group A streptococcal diseases. Lancet Infectious Diseases 2005; 5: 685694.CrossRefGoogle Scholar
2. Facklam, R, et al. emm typing and validation of provisional M types for group A streptococci. Emerging Infectious Diseases 1999; 5: 247253.CrossRefGoogle ScholarPubMed
3. Steer, AC, et al. Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infectious Diseases 2009; 9: 611616.CrossRefGoogle Scholar
4. Meisal, R, et al. Streptococcus pyogenes isolates causing severe infections in Norway in 2006 to 2007: emm types, multilocus sequence types, and superantigen profiles. Journal of Clinical Microbiology 2010; 48: 842851.CrossRefGoogle ScholarPubMed
5. Sakota, V, et al. Genetically diverse group A streptococci from children in far-western Nepal share high genetic relatedness with isolates from other countries. Journal of Clinical Microbiology 2006; 44: 21602166.CrossRefGoogle Scholar
6. Cady, A, et al. Clonal spread of Streptococcus pyogenes emm44 among homeless persons, Rennes, France. Emerging Infectious Diseases 2011; 17: 315317.CrossRefGoogle ScholarPubMed
7. Luca-Harari, B, et al. Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe. Journal of Clinical Microbiology 2009; 47: 11551165.CrossRefGoogle ScholarPubMed
8. Nasser, W, et al. Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3615 genome sequences. Proceedings of the National Academy Sciences USA 2014; 111: E17681776.CrossRefGoogle Scholar
9. Rogers, S, et al. Strain prevalence, rather than innate virulence potential, is the major factor responsible for an increase in serious group A streptococcus infections. Journal of Infectious Disease 2007; 195: 16251633.CrossRefGoogle ScholarPubMed
10. Chen, YY, et al. Molecular epidemiology of group A streptococcus causing scarlet fever in northern Taiwan, 2001–2002. Diagnostic Microbiology and Infectious Disease 2007; 58: 289295.CrossRefGoogle ScholarPubMed
11. Rogers, S, et al. Strain prevalence, rather than innate virulence potential, is the major factor responsible for an increase in serious group A streptococcus infections. Journal of Infectious Disease 2007; 195: 16251633.CrossRefGoogle ScholarPubMed
12. Commons, RJ, et al. Streptococcal superantigens: categorization and clinical associations. Trends in Molecular Medecine 2014; 20: 4862.CrossRefGoogle ScholarPubMed
13. Commons, R, et al. Superantigen genes in group A streptococcal isolates and their relationship with emm types. Journal of Medical Microbiology 2008. 57: 12381246.CrossRefGoogle Scholar
14. Nozawa, T, et al. CRISPR inhibition of prophage acquisition in Streptococcus pyogenes . PLoS ONE 2011; 6: e19543.CrossRefGoogle ScholarPubMed
Figure 0

Fig. 1. Distribution of emm types in group A Streptococcus isolates in Thailand. Bars represent the number of isolates from (a) the Invasive Bacterial Infection Surveillance (IBIS) programme and (b) routine surveillance.

Figure 1

Table 1. Characterization of superantigen gene patterns and emm types of group A Streptococcus isolates in Thailand